Top 10 nektar.com Wettbewerber

biomarin.com

Learn how BioMarin contributes to scientific advancement by supporting independent medical education, external research and publication data requests.

nervgen.com

Investor FAQ Most frequently asked questions and answers Where is NervGen’s stock listed? NervGen trades in Canada on the TSX.V under the symbol NGEN and in the U.S. on the OTCQB under the symbol NGENF. How many NervGen shares are issued and outstanding? Refer to NervGen’s latest filed financial statements for the latest available share […]

tubulis.com

Gilead and Tubulis Enter into Exclusive Option and Licence Agreement to Develop ADC Candidate for Select Solid Tumor Target

xenon-pharma.com

A leading neuroscience company forging new paths for those living with neurological and psychiatric disorders.

apogeetherapeutics.com

Apogee Therapeutics is a clinical stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immune (I&I) diseases with high unmet need

ascendispharma.com

We apply our TransCon technology platform to build a leading, fully integrated biopharma company & make a meaningful difference for patients, caregivers & HCPs.

plustherapeutics.com

Plus Therapeutics is focused on developing innovative, targeted radiotherapeutics for adults & children with difficult-to-treat cancer. Leveraging novel drug formulations and technologies, our drugs are designed to deliver a single, safe and effective dose of radiation directly to the tumor

newdrugapprovals.org

National Medical Products Administration National Medical Products Administration (国家药品监督管理局) Formation 1950 (predecessor organization) 2018 (latest re-organization) Type Ministry-level regulatory …

dementiasplatform.uk

dementias platform uk is a high quality research environment. we make the translation from discoveries to therapeutics easier, better and faster.

imm.ox.ac.uk

the mrc weatherall institute of molecular medicine at the university of oxford was founded in 1989 by sir david weatherall to foster research in molecular and cell biology, with the aim of improving human health. through our excellent basic and applied research we have become leaders in translational medicine. our research has resulted in improved understanding, diagnosis and treatment of a wide range of human diseases.